PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-8.91%
Negative revenue growth while MAXN stands at 0.72%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
41.64%
Positive gross profit growth while MAXN is negative. John Neff would see a clear operational edge over the competitor.
-127.98%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
67.92%
Positive operating income growth while MAXN is negative. John Neff might view this as a competitive edge in operations.
-262.89%
Negative net income growth while MAXN stands at 23.45%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-258.33%
Negative EPS growth while MAXN is at 23.76%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-258.33%
Negative diluted EPS growth while MAXN is at 23.76%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.21%
Share reduction more than 1.5x MAXN's 0.51%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
-1.38%
Reduced diluted shares while MAXN is at 0.51%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-4410.58%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-1144.84%
Negative FCF growth while MAXN is at 49.87%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-54.29%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-14.73%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-17.78%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
48.68%
10Y OCF/share CAGR under 50% of MAXN's 154.56%. Michael Burry would worry about a persistent underperformance in cash creation.
31.34%
Below 50% of MAXN's 154.56%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
40.35%
3Y OCF/share CAGR under 50% of MAXN's 154.56%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
71.54%
Net income/share CAGR above 1.5x MAXN's 42.77% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
80.40%
5Y net income/share CAGR above 1.5x MAXN's 42.77%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
70.03%
3Y net income/share CAGR above 1.5x MAXN's 42.77%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
-81.46%
Both are negative. Martin Whitman suspects the segment is in decline or saddled with persistent unprofitability or write-downs.
-65.29%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
202.35%
Positive short-term equity growth while MAXN is negative. John Neff sees a strong advantage in near-term net worth buildup.
-100.00%
Cut dividends over 10 years while MAXN stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
9.03%
AR growth is negative/stable vs. MAXN's 31.17%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
14.54%
Inventory growth well above MAXN's 23.47%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
1.03%
Asset growth well under 50% of MAXN's 4.09%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
-7.97%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-3.03%
We’re deleveraging while MAXN stands at 35.28%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
14.78%
R&D dropping or stable vs. MAXN's 29.85%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
0.50%
We expand SG&A while MAXN cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.